News | Biotome

top of page

Search

Biotome’s peptide augmentation technology ensures structured orientation and enhanced antibody accessibility.

Biotome’s peptide augmentation technology ensures structured orientation and enhanced antibody accessibility.

Patent Filed: Peptide Augmentation Technology

4 days ago

Biotome Heads to Boston: Meet Us at BIO 2025

Biotome Heads to Boston: Meet Us at BIO 2025

Biotome Heads to Boston: Meet Us at BIO 2025

5 days ago

Our first manufactured 96-well ELISA microplate.

Our first manufactured 96-well ELISA microplate.

Biotome Achieves Manufacturing Milestone in Gastric Cancer Prevention

May 30

Biotome awarded Innovation Booster Grant for preeclampsia risk test development

Biotome awarded Innovation Booster Grant for preeclampsia risk test development

Biotome awarded Innovation Booster Grant for preeclampsia risk test development

Jul 2, 2024

bottom of page